𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Idiotypic antibody immunotherapy of cancer

✍ Scribed by Malaya Bhattacharya Chatterjee; Kenneth A. Foon; Heinz Köhler

Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
1010 KB
Volume
38
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy of pancreatic cancer with
Immunotherapy of pancreatic cancer with monoclonal antibody BW 494
✍ G. Schulz; M. Büchler; K. H. Muhrer; R. Klapdor; R. Kübel; H. P. Harthus; N. Mad 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 593 KB

In a phase I trial 34 patients with pancreatic cancer were treated with the murine monoclonal antibody (MAb) BW 494 (BI 51.011) directed against a glycoprotein antigen. The patients received repeated doses of MAb over a time period from 5 to 14 days (highest single dose 100 mg, highest cumulative do

Clinical outcome of colorectal cancer pa
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody
✍ Gavin W. L. Denton; Lindy G. Durrant; Jack D. Hardcastle; Eric B. Austin; Herb F 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

## Abstract A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their surv

Principles and use of anti-CTLA4 antibod
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy
✍ Karl S Peggs; Sergio A Quezada; Alan J Korman; James P Allison 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Cytotoxic T lymphocyte antigen-4 has become recognized as one of the key negative regulators of adaptive immune responses, having a central role in the maintenance of peripheral tolerance and in shaping the repertoire of emergent T cell responses. Concurrent recognition of the potential importance o